GlaxoSmithKline plc
(the 'Company')
Notification of Transfer of Shares out of Treasury
Pursuant to the Financial Conduct Authority's Listing Rule 12.6.4, the Company hereby notifies the market of the following:
On 15 December 2016, the Company transferred 33,300,000 ordinary shares of 25 pence each ('Ordinary Shares') that were held by the Company in treasury ('Treasury Shares') to the GlaxoSmithKline Employee Benefit Trust to be used specifically to satisfy awards granted under the Company's Deferred Annual Bonus Plan, Performance Share Plan and Share Value Plan. The consideration received was £15.07 pence per Ordinary Share.
Following the transfer, the Company's issued share capital consisted of 5,368,238,025 Ordinary Shares, of which 458,205,950 were held as Treasury Shares.
Therefore, the total number of voting rights in the Company is 4,910,032,075. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
V A Whyte
Company Secretary
16 December 2016